Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612352 · ClinicalTrials.gov registry record · NA
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00612352: Completed NA study, sponsored by Yale University.
NCT00612352 is a NA study that has completed, run by Yale University. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00612352, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Primary Outcome
The Number of Drinks Scale asks Subjects to report on the number of alcoholic drinks they felt they had consumed.
Interventions
- DRUG Ethanol High Dose, Ethanol Low Dose, and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2001-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT00612352 record still lists
NCT00612352 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Ethanol High Dose, Ethanol Low Dose, and Placebo is the first listed.
NCT00612352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00612352 about?
NCT00612352 is a clinical study titled "Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism". The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may l...
What is the current status of trial NCT00612352?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2001-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00612352?
The interventions under investigation include: Ethanol High Dose, Ethanol Low Dose, and Placebo (DRUG).
Who is sponsoring clinical trial NCT00612352?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00612352's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia